|
Introduction on LSDs
Marc C Patterson, Departments of Neurology and Pediatrics, Columbia University, New York, USA, United States
|
|
The concept of therapeutic maintenance
Gregory Pastores, United States
|
|
Miglustat for the long term treatment of patients with Gaucher disease type I
Ari Zimran, Shaare Zedek Medical Center, Israel
|
|
Neurological manifestations in Gaucher disease type I
Marc C Patterson, Departments of Neurology and Pediatrics, Columbia University, New York, USA, United States
|
|
Bone disease in Gaucher disease type I
Gregory Pastores, United States
|
|
Conclusive remarks
Marc C Patterson, Departments of Neurology and Pediatrics, Columbia University, New York, USA, United States
|
|
Discussion
|